| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A SLC34A2 SLC10A3 SLC1A1 SLC1A3 | 1.00e-11 | 171 | 49 | 10 | GO:0015081 |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 1.60e-10 | 5 | 49 | 4 | GO:0052871 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A SLC34A2 SLC10A3 KCNG3 SLC1A1 SLC1A3 ATP2B4 | 9.33e-10 | 465 | 49 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.04e-09 | 81 | 49 | 7 | GO:0015370 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 1.11e-09 | 7 | 49 | 4 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 1.11e-09 | 7 | 49 | 4 | GO:0018685 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A TMEM63B SLC34A2 SLC10A3 KCNG3 SLC1A1 SLC1A3 ATP2B4 | 2.37e-09 | 627 | 49 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | symporter activity | 2.92e-09 | 150 | 49 | 8 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A TMEM63B SLC34A2 SLC10A3 KCNG3 SLC1A1 SLC1A3 ATP2B4 | 4.72e-09 | 664 | 49 | 13 | GO:0008324 |
| GeneOntologyMolecularFunction | transporter activity | SLC38A1 IGF1R SLC34A1 SLCO2B1 TRPM2 SCN8A SLC6A5 SCN10A TMEM63B MFSD2B SLC34A2 SLC10A3 KCNG3 SLC1A1 SLC1A3 ATP2B4 ABCG5 | 4.76e-09 | 1289 | 49 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 6.65e-09 | 10 | 49 | 4 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 6.65e-09 | 10 | 49 | 4 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 6.65e-09 | 10 | 49 | 4 | GO:0102033 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC38A1 SLC34A1 SLCO2B1 TRPM2 SCN8A SLC6A5 SCN10A TMEM63B MFSD2B SLC34A2 SLC10A3 KCNG3 SLC1A1 SLC1A3 ATP2B4 ABCG5 | 1.05e-08 | 1180 | 49 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.56e-08 | 119 | 49 | 7 | GO:0015294 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC38A1 SLC34A1 SLCO2B1 SLC6A5 MFSD2B SLC34A2 SLC10A3 SLC1A1 SLC1A3 ATP2B4 ABCG5 | 1.66e-08 | 477 | 49 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 2.22e-08 | 35 | 49 | 5 | GO:0005343 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 2.25e-08 | 13 | 49 | 4 | GO:0016713 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A TMEM63B SLC34A2 SLC10A3 KCNG3 SLC1A1 SLC1A3 ATP2B4 | 2.28e-08 | 758 | 49 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC38A1 SLC34A1 SLCO2B1 SLC6A5 MFSD2B SLC34A2 SLC10A3 SLC1A1 SLC1A3 | 3.74e-08 | 296 | 49 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A TMEM63B SLC34A2 SLC10A3 KCNG3 SLC1A1 SLC1A3 ATP2B4 | 3.87e-08 | 793 | 49 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.27e-07 | 49 | 49 | 5 | GO:0016712 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 2.74e-07 | 23 | 49 | 4 | GO:0005283 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 3.28e-07 | 24 | 49 | 4 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 5.39e-07 | 27 | 49 | 4 | GO:0008391 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 6.41e-07 | 301 | 49 | 8 | GO:0022853 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 7.26e-07 | 29 | 49 | 4 | GO:0005416 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.58e-06 | 35 | 49 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.74e-06 | 40 | 49 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 3.03e-06 | 41 | 49 | 4 | GO:0015175 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 5.90e-06 | 2 | 49 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 5.90e-06 | 2 | 49 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | arachidonate binding | 6.19e-06 | 15 | 49 | 3 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 7.60e-06 | 16 | 49 | 3 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 7.60e-06 | 16 | 49 | 3 | GO:0050543 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 9.04e-06 | 115 | 49 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.11e-05 | 207 | 49 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.14e-05 | 208 | 49 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | glycine:sodium symporter activity | 1.77e-05 | 3 | 49 | 2 | GO:0015375 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 2.76e-05 | 71 | 49 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | heme binding | 3.71e-05 | 154 | 49 | 5 | GO:0020037 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 4.36e-05 | 28 | 49 | 3 | GO:0036041 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 5.01e-05 | 164 | 49 | 5 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 5.30e-05 | 166 | 49 | 5 | GO:0005506 | |
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 5.87e-05 | 5 | 49 | 2 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 5.87e-05 | 5 | 49 | 2 | GO:0015501 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 7.80e-05 | 293 | 49 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.11e-04 | 194 | 49 | 5 | GO:0016705 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.27e-04 | 105 | 49 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | neutral L-amino acid:sodium symporter activity | 1.64e-04 | 8 | 49 | 2 | GO:0005295 | |
| GeneOntologyMolecularFunction | TAP complex binding | 2.10e-04 | 9 | 49 | 2 | GO:0062061 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 2.10e-04 | 9 | 49 | 2 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP1 binding | 2.62e-04 | 10 | 49 | 2 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 2.62e-04 | 10 | 49 | 2 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 2.62e-04 | 10 | 49 | 2 | GO:0046977 | |
| GeneOntologyMolecularFunction | glycine transmembrane transporter activity | 2.62e-04 | 10 | 49 | 2 | GO:0015187 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.82e-04 | 52 | 49 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 2.92e-04 | 239 | 49 | 5 | GO:0031406 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 3.83e-04 | 12 | 49 | 2 | GO:0005436 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 3.83e-04 | 12 | 49 | 2 | GO:0030881 | |
| GeneOntologyMolecularFunction | organic acid binding | 3.87e-04 | 254 | 49 | 5 | GO:0043177 | |
| GeneOntologyMolecularFunction | glutamate binding | 5.27e-04 | 14 | 49 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | sodium ion binding | 5.27e-04 | 14 | 49 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 6.07e-04 | 15 | 49 | 2 | GO:0005313 | |
| GeneOntologyMolecularFunction | fatty acid binding | 6.49e-04 | 69 | 49 | 3 | GO:0005504 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 7.84e-04 | 17 | 49 | 2 | GO:0046703 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 8.65e-04 | 459 | 49 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 1.09e-03 | 20 | 49 | 2 | GO:0042608 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 1.09e-03 | 20 | 49 | 2 | GO:0015172 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.11e-03 | 83 | 49 | 3 | GO:0015101 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.35e-03 | 196 | 49 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.49e-03 | 343 | 49 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 1.57e-03 | 24 | 49 | 2 | GO:0005315 | |
| GeneOntologyMolecularFunction | channel activity | 1.72e-03 | 525 | 49 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.74e-03 | 526 | 49 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.85e-03 | 26 | 49 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.85e-03 | 26 | 49 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.30e-03 | 107 | 49 | 3 | GO:0033293 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 2.51e-03 | 766 | 49 | 7 | GO:0016491 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 2.79e-03 | 32 | 49 | 2 | GO:0042288 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 3.15e-03 | 34 | 49 | 2 | GO:0015125 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 4.72e-03 | 138 | 49 | 3 | GO:0016614 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 4.77e-03 | 42 | 49 | 2 | GO:0071889 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 5.21e-03 | 143 | 49 | 3 | GO:0017124 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 5.22e-03 | 875 | 49 | 7 | GO:0019904 | |
| GeneOntologyMolecularFunction | sodium channel regulator activity | 5.23e-03 | 44 | 49 | 2 | GO:0017080 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 6.45e-03 | 49 | 49 | 2 | GO:0042605 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 4.20e-10 | 6 | 49 | 4 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 9.78e-10 | 7 | 49 | 4 | GO:0036102 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A SLC34A2 FGF14 ATP2B4 | 1.31e-09 | 208 | 49 | 9 | GO:0035725 |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 1.95e-09 | 8 | 49 | 4 | GO:0036100 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 9.16e-09 | 11 | 49 | 4 | GO:1901523 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 1.26e-08 | 3 | 49 | 3 | GO:0042361 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 1.37e-08 | 12 | 49 | 4 | GO:0042758 | |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A SLC34A2 FGF14 ATP2B4 | 1.51e-08 | 275 | 49 | 9 | GO:0006814 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A TMEM63B SLC34A2 FGF14 KCNG3 ITGB1 SLC1A1 SLC1A3 ATP2B4 | 2.36e-08 | 942 | 49 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 5.03e-08 | 4 | 49 | 3 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 5.03e-08 | 4 | 49 | 3 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 5.03e-08 | 4 | 49 | 3 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 5.03e-08 | 4 | 49 | 3 | GO:0042377 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 6.44e-08 | 230 | 49 | 8 | GO:0098739 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A SLC34A2 FGF14 KCNG3 ITGB1 SLC1A1 SLC1A3 ATP2B4 | 1.54e-07 | 922 | 49 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A TMEM63B SLC34A2 FGF14 KCNG3 ITGB1 SLC1A1 SLC1A3 ATP2B4 | 1.91e-07 | 1115 | 49 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 1.99e-07 | 22 | 49 | 4 | GO:1901569 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 2.51e-07 | 6 | 49 | 3 | GO:1905344 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 2.51e-07 | 6 | 49 | 3 | GO:0062232 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 2.56e-07 | 58 | 49 | 5 | GO:0089718 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A TMEM63B SLC34A2 FGF14 KCNG3 ITGB1 SLC1A1 SLC1A3 ATP2B4 | 3.00e-07 | 1157 | 49 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC38A1 SLC34A1 SLCO2B1 TRPM2 SCN8A SLC6A5 SCN10A TMEM63B SLC34A2 FGF14 KCNG3 ITGB1 SLC1A1 SLC1A3 ATP2B4 | 3.81e-07 | 1374 | 49 | 15 | GO:0006811 |
| GeneOntologyBiologicalProcess | metal ion transport | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A SLC34A2 FGF14 KCNG3 ITGB1 SLC1A1 SLC1A3 ATP2B4 | 3.90e-07 | 1000 | 49 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC38A1 SLC34A1 TRPM2 SCN8A SLC6A5 SCN10A SLC34A2 FGF14 KCNG3 ITGB1 SLC1A1 SLC1A3 ATP2B4 | 4.73e-07 | 1017 | 49 | 13 | GO:0098660 |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 8.16e-07 | 73 | 49 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 1.96e-06 | 87 | 49 | 5 | GO:1902475 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.96e-06 | 87 | 49 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vitamin K metabolic process | 2.05e-06 | 11 | 49 | 3 | GO:0042373 | |
| GeneOntologyBiologicalProcess | vascular transport | 2.07e-06 | 88 | 49 | 5 | GO:0010232 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 2.67e-06 | 41 | 49 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin catabolic process | 2.73e-06 | 12 | 49 | 3 | GO:0042363 | |
| GeneOntologyBiologicalProcess | organic acid catabolic process | 3.44e-06 | 272 | 49 | 7 | GO:0016054 | |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | 3.44e-06 | 272 | 49 | 7 | GO:0046395 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 4.50e-06 | 14 | 49 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 5.03e-06 | 410 | 49 | 8 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 5.21e-06 | 412 | 49 | 8 | GO:0015849 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 5.69e-06 | 108 | 49 | 5 | GO:0015807 | |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 7.00e-06 | 52 | 49 | 4 | GO:0001504 | |
| GeneOntologyBiologicalProcess | circulatory system process | SLC38A1 SLCO2B1 SCN8A SCN10A CYP4F2 CYP4F12 ITGB1 SLC1A1 SLC1A3 ATP2B4 | 7.07e-06 | 733 | 49 | 10 | GO:0003013 |
| GeneOntologyBiologicalProcess | non-proteinogenic amino acid biosynthetic process | 8.37e-06 | 17 | 49 | 3 | GO:0170043 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 9.53e-06 | 120 | 49 | 5 | GO:0003333 | |
| GeneOntologyBiologicalProcess | vitamin catabolic process | 1.00e-05 | 18 | 49 | 3 | GO:0009111 | |
| GeneOntologyBiologicalProcess | L-glutamate import across plasma membrane | 1.19e-05 | 19 | 49 | 3 | GO:0098712 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.24e-05 | 60 | 49 | 4 | GO:0015804 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 1.63e-05 | 21 | 49 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 2.05e-05 | 68 | 49 | 4 | GO:0019369 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid catabolic process | 2.38e-05 | 145 | 49 | 5 | GO:0072329 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | SLC38A1 SLC34A1 CYP4F2 CYP4F3 CYP4F12 ALDH1L1 CYP39A1 CYP4F11 SLC1A3 ATP2B4 ME3 | 2.42e-05 | 1035 | 49 | 11 | GO:0019752 |
| GeneOntologyBiologicalProcess | organic anion transport | 2.62e-05 | 515 | 49 | 8 | GO:0015711 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | SLC38A1 SLC34A1 CYP4F2 CYP4F3 CYP4F12 ALDH1L1 CYP39A1 CYP4F11 SLC1A3 ATP2B4 ME3 | 2.96e-05 | 1058 | 49 | 11 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | SLC38A1 SLC34A1 CYP4F2 CYP4F3 CYP4F12 ALDH1L1 CYP39A1 CYP4F11 SLC1A3 ATP2B4 ME3 | 3.12e-05 | 1064 | 49 | 11 | GO:0006082 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 4.17e-05 | 163 | 49 | 5 | GO:1905039 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 4.29e-05 | 82 | 49 | 4 | GO:1901568 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 4.68e-05 | 167 | 49 | 5 | GO:1903825 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 5.76e-05 | 421 | 49 | 7 | GO:0044282 | |
| GeneOntologyBiologicalProcess | L-glutamate transmembrane transport | 7.82e-05 | 35 | 49 | 3 | GO:0015813 | |
| GeneOntologyBiologicalProcess | D-aspartate import across plasma membrane | 8.24e-05 | 6 | 49 | 2 | GO:0070779 | |
| GeneOntologyBiologicalProcess | D-aspartate transmembrane transport | 8.24e-05 | 6 | 49 | 2 | GO:0070777 | |
| GeneOntologyBiologicalProcess | vitamin E metabolic process | 8.24e-05 | 6 | 49 | 2 | GO:0042360 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid biosynthetic process | 8.24e-05 | 6 | 49 | 2 | GO:0009449 | |
| GeneOntologyBiologicalProcess | L-aspartate import across plasma membrane | 8.24e-05 | 6 | 49 | 2 | GO:0140009 | |
| GeneOntologyBiologicalProcess | amino acid transport | 9.76e-05 | 195 | 49 | 5 | GO:0006865 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 1.17e-04 | 40 | 49 | 3 | GO:0071312 | |
| GeneOntologyBiologicalProcess | hippocampus development | 1.26e-04 | 108 | 49 | 4 | GO:0021766 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | IGF1R SLC34A1 TRPM2 TMEM63B SLC34A2 CYP4F12 CYP39A1 SLC1A1 SLC1A3 ATP2B4 ABCG5 | 1.33e-04 | 1249 | 49 | 11 | GO:0048878 |
| GeneOntologyBiologicalProcess | response to wounding | 1.47e-04 | 659 | 49 | 8 | GO:0009611 | |
| GeneOntologyBiologicalProcess | regulation of pro-B cell differentiation | 1.53e-04 | 8 | 49 | 2 | GO:2000973 | |
| GeneOntologyBiologicalProcess | D-amino acid transport | 1.53e-04 | 8 | 49 | 2 | GO:0042940 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 1.53e-04 | 8 | 49 | 2 | GO:0002485 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid metabolic process | 1.53e-04 | 8 | 49 | 2 | GO:0009448 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 1.54e-04 | 663 | 49 | 8 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 1.55e-04 | 664 | 49 | 8 | GO:0099177 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 1.57e-04 | 344 | 49 | 6 | GO:0003018 | |
| GeneOntologyBiologicalProcess | fatty acid catabolic process | 1.66e-04 | 116 | 49 | 4 | GO:0009062 | |
| GeneOntologyBiologicalProcess | L-glutamate import | 1.78e-04 | 46 | 49 | 3 | GO:0051938 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 2.14e-04 | 124 | 49 | 4 | GO:0001676 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 2.21e-04 | 125 | 49 | 4 | GO:0043279 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 2.26e-04 | 525 | 49 | 7 | GO:0009410 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 2.42e-04 | 128 | 49 | 4 | GO:0033559 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin metabolic process | 2.42e-04 | 51 | 49 | 3 | GO:0006775 | |
| GeneOntologyBiologicalProcess | cellular response to cocaine | 2.46e-04 | 10 | 49 | 2 | GO:0071314 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 2.80e-04 | 133 | 49 | 4 | GO:0006766 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 2.98e-04 | 731 | 49 | 8 | GO:0032787 | |
| GeneOntologyBiologicalProcess | L-aspartate transmembrane transport | 3.00e-04 | 11 | 49 | 2 | GO:0070778 | |
| GeneOntologyBiologicalProcess | intracellular phosphate ion homeostasis | 3.00e-04 | 11 | 49 | 2 | GO:0030643 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 3.02e-04 | 931 | 49 | 9 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 3.02e-04 | 931 | 49 | 9 | GO:0007268 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 3.21e-04 | 939 | 49 | 9 | GO:0099537 | |
| GeneOntologyBiologicalProcess | limbic system development | 3.49e-04 | 141 | 49 | 4 | GO:0021761 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 3.55e-04 | 58 | 49 | 3 | GO:0097106 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 3.59e-04 | 142 | 49 | 4 | GO:0006690 | |
| GeneOntologyBiologicalProcess | regulation of lymphoid progenitor cell differentiation | 3.59e-04 | 12 | 49 | 2 | GO:1905456 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | 3.61e-04 | 752 | 49 | 8 | GO:1901699 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 3.65e-04 | 259 | 49 | 5 | GO:0006836 | |
| GeneOntologyBiologicalProcess | pro-B cell differentiation | 4.24e-04 | 13 | 49 | 2 | GO:0002328 | |
| GeneOntologyBiologicalProcess | sodium-dependent phosphate transport | 4.24e-04 | 13 | 49 | 2 | GO:0044341 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 4.27e-04 | 976 | 49 | 9 | GO:0099536 | |
| GeneOntologyBiologicalProcess | positive regulation of organic acid transport | 4.53e-04 | 63 | 49 | 3 | GO:0032892 | |
| GeneOntologyBiologicalProcess | response to mercury ion | 4.94e-04 | 14 | 49 | 2 | GO:0046689 | |
| GeneOntologyBiologicalProcess | glycine transport | 5.69e-04 | 15 | 49 | 2 | GO:0015816 | |
| GeneOntologyCellularComponent | apical plasma membrane | SLC38A1 SLC34A1 SLCO2B1 SLC34A2 CYP4F2 CYP4F3 CYP4F12 SLC1A1 CYP4F11 ABCG5 | 1.56e-07 | 487 | 49 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | SLC38A1 SLC34A1 SLCO2B1 SLC34A2 CYP4F2 CYP4F3 CYP4F12 SLC1A1 CYP4F11 ABCG5 | 9.34e-07 | 592 | 49 | 10 | GO:0045177 |
| GeneOntologyCellularComponent | secretory granule membrane | 1.09e-05 | 329 | 49 | 7 | GO:0030667 | |
| GeneOntologyCellularComponent | alveolar lamellar body membrane | 1.61e-05 | 3 | 49 | 2 | GO:0097233 | |
| GeneOntologyCellularComponent | lamellar body membrane | 3.22e-05 | 4 | 49 | 2 | GO:0097232 | |
| GeneOntologyCellularComponent | cell surface | SLC38A1 ADAM19 HLA-B SLC34A1 HLA-H LAMP3 CD46 SIRPB1 ITGB1 SLC1A1 SLC1A3 | 4.10e-05 | 1111 | 49 | 11 | GO:0009986 |
| GeneOntologyCellularComponent | presynaptic membrane | 4.45e-05 | 277 | 49 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 9.87e-05 | 320 | 49 | 6 | GO:0016323 | |
| GeneOntologyCellularComponent | secretory granule | HLA-B TRPM2 SLC6A5 HLA-H TMEM63B LAMP3 CD46 SIRPB1 ITGB1 IQUB | 1.01e-04 | 1014 | 49 | 10 | GO:0030141 |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 1.12e-04 | 7 | 49 | 2 | GO:0032398 | |
| GeneOntologyCellularComponent | secretory vesicle | HLA-B PTPRS TRPM2 SLC6A5 HLA-H TMEM63B LAMP3 CD46 SIRPB1 ITGB1 IQUB | 1.15e-04 | 1246 | 49 | 11 | GO:0099503 |
| GeneOntologyCellularComponent | early endosome membrane | 1.36e-04 | 212 | 49 | 5 | GO:0031901 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.71e-04 | 354 | 49 | 6 | GO:0009925 | |
| GeneOntologyCellularComponent | membrane raft | 1.93e-04 | 362 | 49 | 6 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 1.99e-04 | 364 | 49 | 6 | GO:0098857 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 2.39e-04 | 10 | 49 | 2 | GO:0042612 | |
| GeneOntologyCellularComponent | alveolar lamellar body | 2.39e-04 | 10 | 49 | 2 | GO:0097208 | |
| GeneOntologyCellularComponent | basal part of cell | 2.44e-04 | 378 | 49 | 6 | GO:0045178 | |
| GeneOntologyCellularComponent | cell body | 2.69e-04 | 929 | 49 | 9 | GO:0044297 | |
| GeneOntologyCellularComponent | synaptic membrane | 3.93e-04 | 583 | 49 | 7 | GO:0097060 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 4.39e-04 | 785 | 49 | 8 | GO:0098797 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 4.75e-04 | 155 | 49 | 4 | GO:0098685 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 4.81e-04 | 14 | 49 | 2 | GO:0042824 | |
| GeneOntologyCellularComponent | neuronal cell body | 6.61e-04 | 835 | 49 | 8 | GO:0043025 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 7.16e-04 | 17 | 49 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 7.16e-04 | 17 | 49 | 2 | GO:0033106 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | HLA-B PTPRS TRPM2 HLA-H TMEM63B LAMP3 CD46 SIRPB1 ITGB1 SLC1A1 | 7.71e-04 | 1307 | 49 | 10 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | HLA-B PTPRS TRPM2 HLA-H TMEM63B LAMP3 CD46 SIRPB1 ITGB1 SLC1A1 | 8.57e-04 | 1325 | 49 | 10 | GO:0012506 |
| GeneOntologyCellularComponent | glycinergic synapse | 9.95e-04 | 20 | 49 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | lamellar body | 1.10e-03 | 21 | 49 | 2 | GO:0042599 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 1.32e-03 | 23 | 49 | 2 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC protein complex | 1.69e-03 | 26 | 49 | 2 | GO:0042611 | |
| GeneOntologyCellularComponent | recycling endosome | 1.80e-03 | 222 | 49 | 4 | GO:0055037 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 1.97e-03 | 1228 | 49 | 9 | GO:0036477 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.10e-03 | 29 | 49 | 2 | GO:0034706 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.31e-03 | 112 | 49 | 3 | GO:0055038 | |
| GeneOntologyCellularComponent | endosome membrane | 2.72e-03 | 602 | 49 | 6 | GO:0010008 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 2.79e-03 | 817 | 49 | 7 | GO:0098978 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | HLA-B LPCAT4 HLA-H CYP4F2 CYP4F3 CYP4F12 IFI27 CYP39A1 CYP4F11 | 2.80e-03 | 1293 | 49 | 9 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | HLA-B LPCAT4 HLA-H CYP4F2 CYP4F3 CYP4F12 IFI27 CYP39A1 CYP4F11 | 2.89e-03 | 1299 | 49 | 9 | GO:0098827 |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 3.05e-03 | 35 | 49 | 2 | GO:0098553 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 3.15e-03 | 125 | 49 | 3 | GO:0140534 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | HLA-B LPCAT4 HLA-H CYP4F2 CYP4F3 CYP4F12 IFI27 CYP39A1 CYP4F11 | 3.34e-03 | 1327 | 49 | 9 | GO:0042175 |
| GeneOntologyCellularComponent | presynapse | 4.36e-03 | 886 | 49 | 7 | GO:0098793 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 4.37e-03 | 42 | 49 | 2 | GO:0070971 | |
| GeneOntologyCellularComponent | early endosome | 5.24e-03 | 481 | 49 | 5 | GO:0005769 | |
| GeneOntologyCellularComponent | endosome | 5.39e-03 | 1167 | 49 | 8 | GO:0005768 | |
| GeneOntologyCellularComponent | glial cell projection | 5.44e-03 | 47 | 49 | 2 | GO:0097386 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 5.67e-03 | 48 | 49 | 2 | GO:0098576 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 7.18e-03 | 519 | 49 | 5 | GO:0009897 | |
| GeneOntologyCellularComponent | membrane protein complex | 7.35e-03 | 1498 | 49 | 9 | GO:0098796 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 7.41e-03 | 523 | 49 | 5 | GO:0098984 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 9.89e-03 | 64 | 49 | 2 | GO:0012507 | |
| GeneOntologyCellularComponent | sarcolemma | 1.00e-02 | 190 | 49 | 3 | GO:0042383 | |
| GeneOntologyCellularComponent | acrosomal vesicle | 1.25e-02 | 206 | 49 | 3 | GO:0001669 | |
| GeneOntologyCellularComponent | axoneme | 1.26e-02 | 207 | 49 | 3 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.28e-02 | 208 | 49 | 3 | GO:0097014 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.44e-02 | 78 | 49 | 2 | GO:0048787 | |
| GeneOntologyCellularComponent | T-tubule | 1.48e-02 | 79 | 49 | 2 | GO:0030315 | |
| GeneOntologyCellularComponent | perikaryon | 1.54e-02 | 223 | 49 | 3 | GO:0043204 | |
| GeneOntologyCellularComponent | brush border membrane | 1.62e-02 | 83 | 49 | 2 | GO:0031526 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 1.62e-02 | 83 | 49 | 2 | GO:0030670 | |
| Domain | CYTOCHROME_P450 | 3.81e-07 | 57 | 49 | 5 | PS00086 | |
| Domain | - | 4.16e-07 | 58 | 49 | 5 | 1.10.630.10 | |
| Domain | p450 | 4.16e-07 | 58 | 49 | 5 | PF00067 | |
| Domain | Cyt_P450 | 4.94e-07 | 60 | 49 | 5 | IPR001128 | |
| Domain | Cyt_P450_E_grp-I | 5.75e-06 | 45 | 49 | 4 | IPR002401 | |
| Domain | Cyt_P450_CS | 1.11e-05 | 53 | 49 | 4 | IPR017972 | |
| Domain | Na/Pi_transpt | 2.02e-05 | 3 | 49 | 2 | IPR003841 | |
| Domain | Na_Pi_cotrans | 2.02e-05 | 3 | 49 | 2 | PF02690 | |
| Domain | MHC_I_a_C | 1.00e-04 | 6 | 49 | 2 | IPR010579 | |
| Domain | MHC_I_C | 1.00e-04 | 6 | 49 | 2 | PF06623 | |
| Domain | FN3 | 1.21e-04 | 185 | 49 | 5 | SM00060 | |
| Domain | Na-dicarboxylate_symporter | 1.40e-04 | 7 | 49 | 2 | IPR001991 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 1.40e-04 | 7 | 49 | 2 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 1.40e-04 | 7 | 49 | 2 | PS00714 | |
| Domain | Na-dicarboxylate_symporter_CS | 1.40e-04 | 7 | 49 | 2 | IPR018107 | |
| Domain | SDF | 1.40e-04 | 7 | 49 | 2 | PF00375 | |
| Domain | - | 1.40e-04 | 7 | 49 | 2 | 1.10.3860.10 | |
| Domain | FN3 | 1.70e-04 | 199 | 49 | 5 | PS50853 | |
| Domain | FN3_dom | 2.14e-04 | 209 | 49 | 5 | IPR003961 | |
| Domain | Ion_trans_dom | 2.26e-04 | 114 | 49 | 4 | IPR005821 | |
| Domain | Ion_trans | 2.26e-04 | 114 | 49 | 4 | PF00520 | |
| Domain | IG_LIKE | 2.75e-04 | 491 | 49 | 7 | PS50835 | |
| Domain | Na_channel_asu | 2.99e-04 | 10 | 49 | 2 | IPR001696 | |
| Domain | Cyt_P450_E_grp-IV | 2.99e-04 | 10 | 49 | 2 | IPR002403 | |
| Domain | Na_trans_assoc | 2.99e-04 | 10 | 49 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 2.99e-04 | 10 | 49 | 2 | PF06512 | |
| Domain | Ig-like_dom | 3.18e-04 | 503 | 49 | 7 | IPR007110 | |
| Domain | C1-set | 3.83e-04 | 54 | 49 | 3 | PF07654 | |
| Domain | IGc1 | 4.27e-04 | 56 | 49 | 3 | SM00407 | |
| Domain | Channel_four-helix_dom | 4.49e-04 | 57 | 49 | 3 | IPR027359 | |
| Domain | - | 4.49e-04 | 57 | 49 | 3 | 1.20.120.350 | |
| Domain | Ig-like_fold | 4.58e-04 | 706 | 49 | 8 | IPR013783 | |
| Domain | Ig_C1-set | 4.73e-04 | 58 | 49 | 3 | IPR003597 | |
| Domain | Ras_G-nucl-exch_fac_CS | 6.01e-04 | 14 | 49 | 2 | IPR019804 | |
| Domain | fn3 | 8.53e-04 | 162 | 49 | 4 | PF00041 | |
| Domain | RasGEFN | 1.24e-03 | 20 | 49 | 2 | SM00229 | |
| Domain | RasGEF_N | 1.37e-03 | 21 | 49 | 2 | PF00618 | |
| Domain | MHC_I | 1.37e-03 | 21 | 49 | 2 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 1.37e-03 | 21 | 49 | 2 | IPR001039 | |
| Domain | Ras-like_Gua-exchang_fac_N | 1.51e-03 | 22 | 49 | 2 | IPR000651 | |
| Domain | RASGEF_NTER | 1.51e-03 | 22 | 49 | 2 | PS50212 | |
| Domain | Ig_I-set | 1.54e-03 | 190 | 49 | 4 | IPR013098 | |
| Domain | I-set | 1.54e-03 | 190 | 49 | 4 | PF07679 | |
| Domain | - | 1.62e-03 | 663 | 49 | 7 | 2.60.40.10 | |
| Domain | IQ | 1.87e-03 | 93 | 49 | 3 | PS50096 | |
| Domain | RASGEF | 2.11e-03 | 26 | 49 | 2 | PS00720 | |
| Domain | RASGEF_CAT | 2.62e-03 | 29 | 49 | 2 | PS50009 | |
| Domain | RasGEF | 2.80e-03 | 30 | 49 | 2 | PF00617 | |
| Domain | - | 2.80e-03 | 30 | 49 | 2 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 2.80e-03 | 30 | 49 | 2 | IPR023578 | |
| Domain | RASGEF_cat_dom | 2.80e-03 | 30 | 49 | 2 | IPR001895 | |
| Domain | RasGEF | 2.80e-03 | 30 | 49 | 2 | SM00147 | |
| Domain | IGc2 | 3.32e-03 | 235 | 49 | 4 | SM00408 | |
| Domain | Ig_sub2 | 3.32e-03 | 235 | 49 | 4 | IPR003598 | |
| Domain | PTPc | 4.01e-03 | 36 | 49 | 2 | SM00194 | |
| Domain | GDS_CDC24_CS | 4.70e-03 | 39 | 49 | 2 | IPR001331 | |
| Domain | TYR_PHOSPHATASE_PTP | 4.70e-03 | 39 | 49 | 2 | PS50055 | |
| Domain | IG | 4.80e-03 | 421 | 49 | 5 | SM00409 | |
| Domain | Ig_sub | 4.80e-03 | 421 | 49 | 5 | IPR003599 | |
| Domain | PTPase_domain | 5.18e-03 | 41 | 49 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 5.18e-03 | 41 | 49 | 2 | PF00102 | |
| Pathway | REACTOME_EICOSANOIDS | 3.65e-08 | 12 | 43 | 4 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 3.65e-08 | 12 | 43 | 4 | MM14845 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 7.35e-08 | 14 | 43 | 4 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.00e-07 | 15 | 43 | 4 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 2.23e-07 | 18 | 43 | 4 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 2.23e-07 | 18 | 43 | 4 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 9.06e-07 | 25 | 43 | 4 | MM14858 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.18e-06 | 62 | 43 | 5 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.39e-06 | 64 | 43 | 5 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.62e-06 | 66 | 43 | 5 | MM14839 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 2.88e-06 | 33 | 43 | 4 | MM15918 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 2.88e-06 | 33 | 43 | 4 | MM15963 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 4.29e-06 | 11 | 43 | 3 | MM14863 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 5.71e-06 | 12 | 43 | 3 | M27128 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 6.87e-06 | 238 | 43 | 7 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 9.23e-06 | 249 | 43 | 7 | M5988 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.17e-05 | 15 | 43 | 3 | M47485 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 1.20e-05 | 99 | 43 | 5 | M27474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 1.44e-05 | 16 | 43 | 3 | M47483 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 1.49e-05 | 177 | 43 | 6 | M27476 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.53e-05 | 104 | 43 | 5 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.60e-05 | 105 | 43 | 5 | MM14842 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.84e-05 | 108 | 43 | 5 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.92e-05 | 109 | 43 | 5 | MM15074 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC38A1 SLC34A1 SLCO2B1 TRPM2 SLC6A5 SLC34A2 SLC1A1 SLC1A3 ATP2B4 ABCG5 | 2.91e-05 | 681 | 43 | 10 | MM14985 |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 3.38e-05 | 21 | 43 | 3 | M27137 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 3.45e-05 | 61 | 43 | 4 | MM14861 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC38A1 SLC34A1 SLCO2B1 TRPM2 SLC6A5 SLC34A2 SLC1A1 SLC1A3 ATP2B4 ABCG5 | 5.64e-05 | 736 | 43 | 10 | M27287 |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 5.80e-05 | 25 | 43 | 3 | MM1465 | |
| Pathway | BIOCARTA_ERK_PATHWAY | 7.35e-05 | 27 | 43 | 3 | M287 | |
| Pathway | BIOCARTA_ERK_PATHWAY | 8.21e-05 | 28 | 43 | 3 | MM1391 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 9.04e-05 | 5 | 43 | 2 | M27345 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 9.04e-05 | 5 | 43 | 2 | MM15085 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.23e-04 | 32 | 43 | 3 | M27455 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 1.35e-04 | 6 | 43 | 2 | MM14887 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 2.25e-04 | 183 | 43 | 5 | M39588 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 3.23e-04 | 9 | 43 | 2 | M27173 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 3.23e-04 | 9 | 43 | 2 | M39819 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 3.23e-04 | 9 | 43 | 2 | MM14527 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 3.66e-04 | 46 | 43 | 3 | M27151 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS | 4.03e-04 | 10 | 43 | 2 | M47930 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 4.16e-04 | 48 | 43 | 3 | MM15902 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 4.91e-04 | 11 | 43 | 2 | MM15578 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 4.91e-04 | 11 | 43 | 2 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 4.91e-04 | 11 | 43 | 2 | M47432 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 5.00e-04 | 335 | 43 | 6 | MM14503 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 5.15e-04 | 219 | 43 | 5 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 5.25e-04 | 220 | 43 | 5 | M10320 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 5.88e-04 | 54 | 43 | 3 | MM14871 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 6.45e-04 | 130 | 43 | 4 | M27454 | |
| Pathway | WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION | 6.83e-04 | 132 | 43 | 4 | M48110 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 6.94e-04 | 13 | 43 | 2 | M47594 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1 | 6.94e-04 | 13 | 43 | 2 | M6322 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 7.63e-04 | 59 | 43 | 3 | M27140 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 8.08e-04 | 14 | 43 | 2 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 8.08e-04 | 14 | 43 | 2 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 8.08e-04 | 14 | 43 | 2 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 8.08e-04 | 14 | 43 | 2 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 8.08e-04 | 14 | 43 | 2 | M47378 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 8.08e-04 | 14 | 43 | 2 | M27858 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 8.08e-04 | 14 | 43 | 2 | M47488 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47640 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.31e-04 | 15 | 43 | 2 | M47531 | |
| Pathway | KEGG_GLIOMA | 1.01e-03 | 65 | 43 | 3 | M1835 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.06e-03 | 16 | 43 | 2 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.06e-03 | 16 | 43 | 2 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 1.06e-03 | 16 | 43 | 2 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 1.06e-03 | 16 | 43 | 2 | M47804 | |
| Pathway | WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER | 1.06e-03 | 16 | 43 | 2 | M39882 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 1.11e-03 | 67 | 43 | 3 | M295 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.20e-03 | 17 | 43 | 2 | M47376 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 1.20e-03 | 17 | 43 | 2 | M27918 | |
| Pathway | BIOCARTA_PTEN_PATHWAY | 1.35e-03 | 18 | 43 | 2 | M10145 | |
| Pathway | BIOCARTA_PTEN_PATHWAY | 1.35e-03 | 18 | 43 | 2 | MM1461 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 1.35e-03 | 18 | 43 | 2 | MM14525 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.45e-03 | 411 | 43 | 6 | M735 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 1.67e-03 | 20 | 43 | 2 | MM1374 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.67e-03 | 20 | 43 | 2 | M27290 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.67e-03 | 20 | 43 | 2 | MM15485 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.67e-03 | 20 | 43 | 2 | MM14991 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 1.72e-03 | 78 | 43 | 3 | M973 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 1.75e-03 | 170 | 43 | 4 | MM15573 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.84e-03 | 21 | 43 | 2 | M27736 | |
| Pathway | BIOCARTA_IGF1_PATHWAY | 1.84e-03 | 21 | 43 | 2 | M2623 | |
| Pathway | BIOCARTA_IGF1_PATHWAY | 2.02e-03 | 22 | 43 | 2 | MM1409 | |
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 3.48e-12 | 4 | 49 | 4 | 18065749 | |
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 9068972 | ||
| Pubmed | 8.25e-09 | 105 | 49 | 6 | 30280653 | ||
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 22665481 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 1.05e-08 | 4 | 49 | 3 | 11185557 | |
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 22969154 | ||
| Pubmed | Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. | 2.62e-08 | 5 | 49 | 3 | 21466787 | |
| Pubmed | 5.08e-08 | 70 | 49 | 5 | 15128046 | ||
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 22160543 | ||
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 4.53e-07 | 44 | 49 | 4 | 12745259 | |
| Pubmed | 8.95e-07 | 52 | 49 | 4 | 26590417 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15289498 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15363892 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24138531 | ||
| Pubmed | Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies. | 1.94e-06 | 2 | 49 | 2 | 18662666 | |
| Pubmed | Expression and physiological function of CYP4F subfamily in human eosinophils. | 1.94e-06 | 2 | 49 | 2 | 17980168 | |
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 1.94e-06 | 2 | 49 | 2 | 8026587 | |
| Pubmed | Integrin expression regulates neuroblastoma attachment and migration. | 1.94e-06 | 2 | 49 | 2 | 15256055 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17899316 | ||
| Pubmed | FGF14 localization and organization of the axon initial segment. | 1.94e-06 | 2 | 49 | 2 | 23891806 | |
| Pubmed | A homologue of the Drosophila Son of sevenless gene maps to mouse chromosome 17. | 1.94e-06 | 2 | 49 | 2 | 8307589 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25973715 | ||
| Pubmed | HLA-B influences integrin beta-1 expression and pancreatic cancer cell migration. | 1.94e-06 | 2 | 49 | 2 | 32194036 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26994141 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23640885 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15364545 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 32671946 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 1631150 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 9566880 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17574207 | ||
| Pubmed | SOS2 Comes to the Fore: Differential Functionalities in Physiology and Pathology. | 1.94e-06 | 2 | 49 | 2 | 34205562 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 7859077 | ||
| Pubmed | Type II Na+-Pi cotransporters in osteoblast mineral formation: regulation by inorganic phosphate. | 1.94e-06 | 2 | 49 | 2 | 17310099 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 9372945 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22364545 | ||
| Pubmed | Cloning and expression of a glutamate transporter from mouse brain. | 1.94e-06 | 2 | 49 | 2 | 7903437 | |
| Pubmed | Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia. | 1.94e-06 | 2 | 49 | 2 | 36010887 | |
| Pubmed | Functional Modulation of Voltage-Gated Sodium Channels by a FGF14-Based Peptidomimetic. | 1.94e-06 | 2 | 49 | 2 | 29359916 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 8275713 | ||
| Pubmed | Expression of renal and intestinal Na/Pi cotransporters in the absence of GABARAP. | 5.83e-06 | 3 | 49 | 2 | 20354864 | |
| Pubmed | The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. | 5.83e-06 | 3 | 49 | 2 | 17607354 | |
| Pubmed | Increased expression and function of glutamate transporters in multiple sclerosis. | 5.83e-06 | 3 | 49 | 2 | 16061389 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 11880379 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 16516348 | ||
| Pubmed | Insulin regulates neurovascular coupling through astrocytes. | 5.83e-06 | 3 | 49 | 2 | 35858325 | |
| Pubmed | Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. | 5.83e-06 | 3 | 49 | 2 | 15145985 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 5.83e-06 | 3 | 49 | 2 | 31985401 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20139422 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 37648036 | ||
| Pubmed | Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival. | 5.83e-06 | 3 | 49 | 2 | 32458278 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 9784606 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 7799946 | ||
| Pubmed | Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival. | 5.83e-06 | 3 | 49 | 2 | 24043312 | |
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 5.83e-06 | 3 | 49 | 2 | 33656439 | |
| Pubmed | Distribution of glutamate transporters in the human placenta. | 5.83e-06 | 3 | 49 | 2 | 15135231 | |
| Pubmed | Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. | 5.83e-06 | 3 | 49 | 2 | 7521911 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 33477899 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 12628188 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 17727989 | ||
| Pubmed | Differential Role of the RasGEFs Sos1 and Sos2 in Mouse Skin Homeostasis and Carcinogenesis. | 5.83e-06 | 3 | 49 | 2 | 29844066 | |
| Pubmed | Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion. | 5.83e-06 | 3 | 49 | 2 | 25394468 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 32585762 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 16429462 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 27208619 | ||
| Pubmed | Molecular regulation of antioxidant ability in the hippocampus of EL mice. | 5.83e-06 | 3 | 49 | 2 | 18621028 | |
| Pubmed | Conditional knockout of NaV1.6 in adult mice ameliorates neuropathic pain. | 5.83e-06 | 3 | 49 | 2 | 29497094 | |
| Pubmed | Dynamic changes in expression of glutamate transporter mRNAs in developing brain. | 5.83e-06 | 3 | 49 | 2 | 8733726 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 17221839 | ||
| Pubmed | Upregulation of the Na⁺-coupled phosphate cotransporters NaPi-IIa and NaPi-IIb by B-RAF. | 5.83e-06 | 3 | 49 | 2 | 24258620 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20220082 | ||
| Pubmed | JAK2 regulates Nav1.6 channel function via FGF14Y158 phosphorylation. | 5.83e-06 | 3 | 49 | 2 | 32599005 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 22586275 | ||
| Pubmed | Interleukin-1 attenuates normal tension glaucoma-like retinal degeneration in EAAC1-deficient mice. | 5.83e-06 | 3 | 49 | 2 | 19766171 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18491034 | ||
| Pubmed | Disassembly of Son-of-sevenless proteins from Grb2 during p21ras desensitization by insulin. | 5.83e-06 | 3 | 49 | 2 | 7829473 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 7629138 | ||
| Pubmed | 7.81e-06 | 193 | 49 | 5 | 19343046 | ||
| Pubmed | Expression of Glutamate Transporters in Mouse Liver, Kidney, and Intestine. | 1.16e-05 | 4 | 49 | 2 | 29303644 | |
| Pubmed | SIRPα Mediates IGF1 Receptor in Cardiomyopathy Induced by Chronic Kidney Disease. | 1.16e-05 | 4 | 49 | 2 | 35722884 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 22424243 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 15140926 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 32768484 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 25659151 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 29398136 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 19233126 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 33477820 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 16600856 | ||
| Pubmed | Caveolin-1 Sensitivity of Excitatory Amino Acid Transporters EAAT1, EAAT2, EAAT3, and EAAT4. | 1.16e-05 | 4 | 49 | 2 | 26690923 | |
| Pubmed | A new member of the amphiphysin family connecting endocytosis and signal transduction pathways. | 1.16e-05 | 4 | 49 | 2 | 9182529 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 8524829 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 9379843 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 31337738 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 10940929 | ||
| Pubmed | Insulin and Insulin-Like Growth Factor 1 Signaling Preserves Sarcomere Integrity in the Adult Heart. | 1.94e-05 | 5 | 49 | 2 | 36125265 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 9030684 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 9129177 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 10777529 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 18413316 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 22357843 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 23209318 | ||
| Interaction | OPALIN interactions | 9.88e-06 | 209 | 48 | 6 | int:OPALIN | |
| Cytoband | 2p21 | 3.94e-05 | 61 | 49 | 3 | 2p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.99e-04 | 797 | 49 | 6 | chr19p13 | |
| Cytoband | 19p13.1 | 1.22e-03 | 48 | 49 | 2 | 19p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p21 | 3.34e-03 | 80 | 49 | 2 | chr2p21 | |
| GeneFamily | Cytochrome P450 family 4 | 9.31e-07 | 36 | 38 | 4 | 1003 | |
| GeneFamily | Solute carriers | SLC38A1 SLC34A1 SLCO2B1 SLC6A5 SLC34A2 SLC10A3 SLC1A1 SLC1A3 | 1.33e-06 | 395 | 38 | 8 | 752 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.53e-04 | 9 | 38 | 2 | 1203 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.53e-04 | 161 | 38 | 4 | 593 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 8.81e-04 | 21 | 38 | 2 | 813 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.33e-03 | 394 | 38 | 5 | 471 | |
| GeneFamily | C1-set domain containing | 3.51e-03 | 42 | 38 | 2 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 3.85e-03 | 44 | 38 | 2 | 588 | |
| GeneFamily | Fibronectin type III domain containing | 4.57e-03 | 160 | 38 | 3 | 555 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.48e-03 | 66 | 38 | 2 | 722 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SLC38A1 TMEM161A IGF1R GANAB HLA-B PTPRS HLA-H TMEM63B SLC10A3 ITGB1 | 5.77e-07 | 703 | 49 | 10 | MM1055 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 2.38e-06 | 470 | 49 | 8 | MM1053 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SLC38A1 TMEM161A IGF1R GANAB HLA-B PTPRS TMEM63B SLC10A3 ITGB1 | 4.15e-06 | 681 | 49 | 9 | M5314 |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 6.84e-06 | 20 | 49 | 3 | MM1104 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_DN | 1.39e-05 | 78 | 49 | 4 | M9911 | |
| Coexpression | GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN | 2.16e-05 | 180 | 49 | 5 | M6317 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | 3.37e-05 | 330 | 49 | 6 | MM1120 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_B_CELL_AGEING | 5.57e-05 | 111 | 49 | 4 | MM3831 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_DISTAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 8.57e-05 | 124 | 49 | 4 | MM3726 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING | 1.65e-04 | 147 | 49 | 4 | MM3753 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 2.02e-04 | 457 | 49 | 6 | M1613 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_METANEPHRIC_CELLS | 2.13e-04 | 157 | 49 | 4 | M40223 | |
| Coexpression | NFE2L2.V2 | 2.32e-04 | 469 | 49 | 6 | M2870 | |
| Coexpression | JONES_OVARY_ENDOTHELIAL | 2.40e-04 | 162 | 49 | 4 | M48350 | |
| Coexpression | DURAND_STROMA_S_UP | 2.40e-04 | 300 | 49 | 5 | M2581 | |
| Coexpression | DURAND_STROMA_S_UP | 2.55e-04 | 304 | 49 | 5 | MM1083 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_UP | 2.63e-04 | 166 | 49 | 4 | M6688 | |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP | 3.29e-04 | 176 | 49 | 4 | M15588 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN | 3.51e-04 | 179 | 49 | 4 | M16932 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_MYELOID_CELLS | 3.97e-04 | 185 | 49 | 4 | M40148 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 4.04e-04 | 16 | 49 | 2 | MM3766 | |
| Coexpression | GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP | 4.22e-04 | 188 | 49 | 4 | M3300 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 4.39e-04 | 190 | 49 | 4 | MM1311 | |
| Coexpression | GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP | 4.57e-04 | 192 | 49 | 4 | M4923 | |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | 4.67e-04 | 535 | 49 | 6 | MM3635 | |
| Coexpression | P53_DN.V1_UP | 4.75e-04 | 194 | 49 | 4 | M2698 | |
| Coexpression | GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_DN | 4.75e-04 | 194 | 49 | 4 | M6134 | |
| Coexpression | LTE2_UP.V1_DN | 4.84e-04 | 195 | 49 | 4 | M2721 | |
| Coexpression | GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 4.94e-04 | 196 | 49 | 4 | M5349 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_PROXIMAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 4.94e-04 | 196 | 49 | 4 | MM3730 | |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 | 5.03e-04 | 197 | 49 | 4 | M12824 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP | 5.03e-04 | 197 | 49 | 4 | M9969 | |
| Coexpression | GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN | 5.03e-04 | 197 | 49 | 4 | M3105 | |
| Coexpression | GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN | 5.13e-04 | 198 | 49 | 4 | M3302 | |
| Coexpression | GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP | 5.13e-04 | 198 | 49 | 4 | M8985 | |
| Coexpression | GSE3982_MAC_VS_NKCELL_DN | 5.13e-04 | 198 | 49 | 4 | M5509 | |
| Coexpression | GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN | 5.23e-04 | 199 | 49 | 4 | M6290 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN | 5.33e-04 | 200 | 49 | 4 | M9570 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_UP | 5.33e-04 | 200 | 49 | 4 | M8569 | |
| Coexpression | GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 5.33e-04 | 200 | 49 | 4 | M7198 | |
| Coexpression | GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_DN | 5.33e-04 | 200 | 49 | 4 | M9861 | |
| Coexpression | GSE7852_TREG_VS_TCONV_THYMUS_UP | 5.33e-04 | 200 | 49 | 4 | M5730 | |
| Coexpression | GSE7460_TCONV_VS_TREG_THYMUS_DN | 5.33e-04 | 200 | 49 | 4 | M5676 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9 | 5.44e-04 | 85 | 49 | 3 | MM1279 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 5.74e-04 | 19 | 49 | 2 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 5.74e-04 | 19 | 49 | 2 | MM862 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | 5.74e-04 | 204 | 49 | 4 | MM17090 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 5.83e-04 | 87 | 49 | 3 | MM652 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 6.37e-04 | 20 | 49 | 2 | MM3682 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_3 | 6.37e-04 | 20 | 49 | 2 | M39043 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 6.43e-04 | 90 | 49 | 3 | MM3756 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 6.86e-04 | 92 | 49 | 3 | MM3748 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 7.03e-04 | 21 | 49 | 2 | MM651 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-06 | 176 | 49 | 5 | 2bc4d3ddc2f752d8255dec0e7a9b87c7f82a372d | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-06 | 181 | 49 | 5 | 79102845baee5af583eec24e9f91dfec46ab7de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 183 | 49 | 5 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-06 | 184 | 49 | 5 | 22c18964818fc9c8f18051f836d718937b0d8d12 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 187 | 49 | 5 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 187 | 49 | 5 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | BAL|World / Compartment, Disease Groups and Clusters | 2.37e-06 | 195 | 49 | 5 | f59faf77fc7d7fd7ddb9d4d6d469951d5066bebb | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.81e-05 | 159 | 49 | 4 | b3c52908cd24bbf851fac69db3850fc7f53c2092 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.17e-05 | 164 | 49 | 4 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-05 | 164 | 49 | 4 | fe11fcce4ba7f44ba2989ea3705916b67e75f8e7 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-05 | 164 | 49 | 4 | b6beb8548ac0dd07e8a580a938e5ee4bf25a3c1f | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.17e-05 | 164 | 49 | 4 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.17e-05 | 164 | 49 | 4 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-05 | 167 | 49 | 4 | 1bd0aa7a3c8649f342bb856cf861c4c5984ad889 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.49e-05 | 168 | 49 | 4 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.91e-05 | 173 | 49 | 4 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 4.27e-05 | 177 | 49 | 4 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.37e-05 | 178 | 49 | 4 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.46e-05 | 179 | 49 | 4 | a634ca46ffc394c5f5215fc5d8eae4a77819af9c | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.46e-05 | 179 | 49 | 4 | 35f014b6e752626909d829c5ab9bb761c1f3e3dc | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 4.46e-05 | 179 | 49 | 4 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 4.46e-05 | 179 | 49 | 4 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-05 | 180 | 49 | 4 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.56e-05 | 180 | 49 | 4 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 4.56e-05 | 180 | 49 | 4 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.56e-05 | 180 | 49 | 4 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.66e-05 | 181 | 49 | 4 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 182 | 49 | 4 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.76e-05 | 182 | 49 | 4 | ea39b1b5db185b0cb11dfa2e01f3f972effbd770 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 182 | 49 | 4 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 184 | 49 | 4 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 184 | 49 | 4 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 4.97e-05 | 184 | 49 | 4 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 5.07e-05 | 185 | 49 | 4 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.07e-05 | 185 | 49 | 4 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-05 | 186 | 49 | 4 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-05 | 186 | 49 | 4 | 422d24e3e1a9397bb7d5c7ef75de2fd7ae8e136d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-05 | 186 | 49 | 4 | 8287146f0ba415ea04475588117d4668ae00f75c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-05 | 186 | 49 | 4 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.18e-05 | 186 | 49 | 4 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-05 | 186 | 49 | 4 | 65da0666a10a59f8cc379589860a2e98fe487754 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-05 | 186 | 49 | 4 | dc84fef1ca2f5d5d818b76a3321559e87d1c4a4d | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.29e-05 | 187 | 49 | 4 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 49 | 4 | 1b82920588f9e26ef1db244d452736d75fcfd342 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 49 | 4 | 71eb26ebf60cb0848e5bf1cd01edccda621aecd8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.29e-05 | 187 | 49 | 4 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 187 | 49 | 4 | 236e9857729670e87eed30fad58f49e1f56e4a85 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 49 | 4 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 188 | 49 | 4 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 188 | 49 | 4 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 188 | 49 | 4 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-05 | 189 | 49 | 4 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-05 | 189 | 49 | 4 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.51e-05 | 189 | 49 | 4 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.63e-05 | 190 | 49 | 4 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.63e-05 | 190 | 49 | 4 | 55df73c8b696967a925b1772631f6900eff0fa30 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.63e-05 | 190 | 49 | 4 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.63e-05 | 190 | 49 | 4 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.63e-05 | 190 | 49 | 4 | 494fbab37305a7f92cddec75b291d42282555f5f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.63e-05 | 190 | 49 | 4 | e67d9400467b438592690b23d681e6c2fb8f09fd | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.74e-05 | 191 | 49 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 5.74e-05 | 191 | 49 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.74e-05 | 191 | 49 | 4 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.86e-05 | 192 | 49 | 4 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.86e-05 | 192 | 49 | 4 | e07b6892276c81c1227e94ca942f6820d89a7ca3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.86e-05 | 192 | 49 | 4 | fdc741e1846cfd8ed741b160e3c611c310c5d36d | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.86e-05 | 192 | 49 | 4 | 0f8c63de26128694f4522f9f6d029e4628c890bc | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.10e-05 | 194 | 49 | 4 | 0b0042b6a356a49a059fb64a1e1abb25c82d48cf | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.10e-05 | 194 | 49 | 4 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 6.22e-05 | 195 | 49 | 4 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-05 | 195 | 49 | 4 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | 3'-Child09-12|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-05 | 196 | 49 | 4 | 1bcc4ffff51cdb6211824686c2422c43b09e24b2 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.35e-05 | 196 | 49 | 4 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 6.47e-05 | 197 | 49 | 4 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.47e-05 | 197 | 49 | 4 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | Control-Lymphoid-CD4_T_cells|Control / Condition, Lineage and Cell class | 6.47e-05 | 197 | 49 | 4 | dad6479caac07c1536f2b3082a51d61ae08beca0 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.47e-05 | 197 | 49 | 4 | 927bf36bad3bcb7346c13b660777c1c0de7dc322 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.47e-05 | 197 | 49 | 4 | 3e09158507df08c08e08613ce23617206280c911 | |
| ToppCell | Monocytes-Phagocytic_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.60e-05 | 198 | 49 | 4 | 09009cc966bf1503c3b15dfa079a6c5f6ad1f507 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17|Lung / Manually curated celltypes from each tissue | 6.73e-05 | 199 | 49 | 4 | 1acf522a5d296042fe9f1cb47c1a06fc22da75a3 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | 368e2bafae00ce8e9c6ea480f81b78f96b680acd | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_Tem|Control / Disease, condition lineage and cell class | 6.86e-05 | 200 | 49 | 4 | fddb3df5b90eb97ef8ed80fac320c1a90903f012 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.06e-05 | 79 | 49 | 3 | 03c5af851b53800eced1c74e9da374c71092bcd4 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Endothelial|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.65e-04 | 22 | 49 | 2 | 124067c169b11131084e634b8c29fd855b8eb231 | |
| ToppCell | VE-CD4-CD8_2|VE / Condition, Cell_class and T cell subcluster | 3.27e-04 | 122 | 49 | 3 | 6745035feaf807b6a6b9537ac9d5ee0e000196eb | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B3|TCGA-Thymus / Sample_Type by Project: Shred V9 | 3.85e-04 | 129 | 49 | 3 | c760a1f9b86f086074e6e04e50ab40da3639e5fb | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC2|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.89e-04 | 140 | 49 | 3 | c3331cb7720f93af8bab35d02c6cbe87dd324d91 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.10e-04 | 142 | 49 | 3 | 369f2e51e0283a4de70e6c7a3b95672c0838f205 | |
| ToppCell | Epithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4) | 5.53e-04 | 146 | 49 | 3 | 4511916904c1fac252cb68e871b782207f8137b3 | |
| ToppCell | metastatic_Brain-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 5.64e-04 | 147 | 49 | 3 | 4f7a0c287721befeffabf95b8c5f9ff64149c7c1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.64e-04 | 147 | 49 | 3 | a82a971a934faff6806823ca62a398b429ecd9c8 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-Trm_Th1/Th17|bone_marrow / Manually curated celltypes from each tissue | 5.87e-04 | 149 | 49 | 3 | 264fe2ceac6379b3394d2bb47ef34692e4a64559 | |
| ToppCell | remission-multiplets|remission / disease stage, cell group and cell class | 5.87e-04 | 149 | 49 | 3 | e9974260a5f2999b363f306cae005698c912893a | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-04 | 150 | 49 | 3 | 6e806a028c0519489151c181d9907e05289e27e0 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.98e-04 | 150 | 49 | 3 | b6f1fc62d08199fed6156c7cd32f66d9926531b5 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-04 | 153 | 49 | 3 | 764fb5e5fa028c137b8ea65dcd5e4ec9b22191e9 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 6.46e-04 | 154 | 49 | 3 | 89a60a79d07466d7ad05888d10a72d3b1ab384af | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 6.46e-04 | 154 | 49 | 3 | f1fea1a87e977221fa125b62287368be9af4987d | |
| ToppCell | Healthy_donor-RBC|Healthy_donor / disease group, cell group and cell class (v2) | 6.46e-04 | 154 | 49 | 3 | e080d5104fe6f3f6ef617bbcdccf1332ab7231e1 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-04 | 154 | 49 | 3 | 75eac6970259a6916fcfa6d3400509cfa2d98d9d | |
| Computational | Neighborhood of GSTM1 | 3.67e-04 | 109 | 34 | 4 | GNF2_GSTM1 | |
| Computational | Neighborhood of LCAT | 5.99e-04 | 124 | 34 | 4 | GNF2_LCAT | |
| Computational | Neighborhood of HPN | 8.01e-04 | 134 | 34 | 4 | GNF2_HPN | |
| Computational | Neighborhood of HPX | 8.24e-04 | 135 | 34 | 4 | GNF2_HPX | |
| Drug | sodium | SLC38A1 SLC34A1 SLCO2B1 TRPM2 SLC6A5 SCN10A SLC34A2 SLC10A3 SLC1A1 SLC1A3 ATP2B4 SOS1 SOS2 | 6.46e-08 | 944 | 49 | 13 | CID000000923 |
| Drug | bumetanide | 3.08e-07 | 209 | 49 | 7 | CID000002471 | |
| Drug | propoxyphene | 3.27e-07 | 67 | 49 | 5 | CID000010100 | |
| Drug | carteolol | 4.70e-07 | 72 | 49 | 5 | CID000002583 | |
| Drug | arsenic pentoxide | 5.21e-07 | 8 | 49 | 3 | ctd:C042120 | |
| Drug | trimipramine | 7.97e-07 | 80 | 49 | 5 | CID000005584 | |
| Drug | diosmetin | 1.08e-06 | 85 | 49 | 5 | CID005281612 | |
| Drug | hydride | SLC34A1 CYP4F2 CYP4F12 ALDH1L1 CYP39A1 SLC1A1 CYP4F11 SLC1A3 ATP2B4 SOS1 SOS2 | 1.23e-06 | 835 | 49 | 11 | CID000000783 |
| Drug | mephenytoin | 1.28e-06 | 88 | 49 | 5 | CID000004060 | |
| Drug | tienilic acid | 1.69e-06 | 93 | 49 | 5 | CID000038409 | |
| Drug | lansoprazole | 1.69e-06 | 93 | 49 | 5 | CID000003883 | |
| Drug | dichloran | 1.81e-06 | 41 | 49 | 4 | CID000007430 | |
| Drug | L-alanosine | 1.81e-06 | 41 | 49 | 4 | CID000022128 | |
| Drug | AC1L1KIN | 2.42e-06 | 100 | 49 | 5 | CID000005516 | |
| Drug | Sparteinum | 2.54e-06 | 101 | 49 | 5 | CID000003966 | |
| Drug | alprazolam | 3.54e-06 | 193 | 49 | 6 | CID000002118 | |
| Drug | Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.87e-06 | 196 | 49 | 6 | 2871_UP | |
| Drug | rifampicin | 3.92e-06 | 306 | 49 | 7 | CID005381226 | |
| Drug | betaine | 4.35e-06 | 200 | 49 | 6 | CID000000247 | |
| Drug | AC1Q7AUJ | 5.23e-06 | 117 | 49 | 5 | CID000003303 | |
| Drug | 8-MOP | 5.46e-06 | 118 | 49 | 5 | CID000004114 | |
| Drug | hexobarbital | 7.82e-06 | 127 | 49 | 5 | CID000003608 | |
| Drug | chloral hydrate | 8.43e-06 | 129 | 49 | 5 | CID000002707 | |
| Drug | senkirkine | 9.03e-06 | 61 | 49 | 4 | ctd:C009238 | |
| Drug | aminoglutethimide | 1.13e-05 | 137 | 49 | 5 | CID000002145 | |
| Drug | methylisobutylamiloride | 1.21e-05 | 21 | 49 | 3 | CID000073314 | |
| Drug | ebastine | 2.08e-05 | 25 | 49 | 3 | CID000003191 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A | 2.39e-05 | 160 | 49 | 5 | 6133_DN | |
| Drug | furosemide | 2.50e-05 | 272 | 49 | 6 | CID000003440 | |
| Drug | paraoxon | 2.69e-05 | 164 | 49 | 5 | CID000009395 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 2.71e-05 | 4 | 49 | 2 | ctd:C501880 | |
| Drug | YVN | 2.71e-05 | 4 | 49 | 2 | CID009547990 | |
| Drug | felodipine | 3.11e-05 | 169 | 49 | 5 | CID000003333 | |
| Drug | aminopyrine | 3.29e-05 | 171 | 49 | 5 | CID000006009 | |
| Drug | sarcolysin | 3.38e-05 | 172 | 49 | 5 | CID000004053 | |
| Drug | alpha-(methylamino)isobutyric acid | 4.04e-05 | 31 | 49 | 3 | CID000075725 | |
| Drug | His-pro-dkp | 4.04e-05 | 31 | 49 | 3 | CID000065137 | |
| Drug | carbamazepine | 4.09e-05 | 179 | 49 | 5 | CID000002554 | |
| Drug | metyrapone | 4.09e-05 | 179 | 49 | 5 | CID000004174 | |
| Drug | potassium | SLC38A1 SLC6A5 SCN10A SLC10A3 KCNG3 SLC1A1 SLC1A3 ATP2B4 SOS1 SOS2 | 4.71e-05 | 1008 | 49 | 10 | CID000000813 |
| Drug | clofibrate | 5.28e-05 | 311 | 49 | 6 | CID000002796 | |
| Drug | ethylnylestradiol | IGF1R SLC34A1 SLC34A2 CYP4F2 CYP4F3 CYP4F12 IFI27 CYP39A1 CYP4F11 SLC1A3 ABCG5 | 5.57e-05 | 1251 | 49 | 11 | CID000003285 |
| Drug | halothane | 5.57e-05 | 314 | 49 | 6 | CID000003562 | |
| Drug | ethyldichloroarsine | 5.84e-05 | 35 | 49 | 3 | CID000011711 | |
| Drug | propafenone | 5.89e-05 | 98 | 49 | 4 | CID000004932 | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; PC3; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 5049_DN | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 4991_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 5416_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 3971_UP | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 2889_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 4764_DN | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 5415_DN | |
| Drug | NSC98537 | 6.45e-05 | 473 | 49 | 7 | CID000005410 | |
| Drug | Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 5886_UP | |
| Drug | tolbutamide | 6.61e-05 | 198 | 49 | 5 | CID000005505 | |
| Drug | Azacyclonol [115-46-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 5398_DN | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 4748_UP | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; PC3; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 3764_UP | |
| Drug | APETx1, Anthopleura elegantissima | 6.77e-05 | 6 | 49 | 2 | ctd:C475726 | |
| Drug | sipatrigine | 6.91e-05 | 37 | 49 | 3 | CID000060803 | |
| Drug | AC1O5PIQ | 8.11e-05 | 39 | 49 | 3 | CID006438348 | |
| Drug | diclofenac | 8.53e-05 | 209 | 49 | 5 | CID000003032 | |
| Drug | desvenlafaxine | 9.43e-05 | 41 | 49 | 3 | CID000125017 | |
| Drug | 3-hydroxystearate | 9.46e-05 | 7 | 49 | 2 | CID005282907 | |
| Drug | dioxin | 9.66e-05 | 347 | 49 | 6 | CID000015625 | |
| Drug | phenobarbital | 1.18e-04 | 360 | 49 | 6 | CID000004763 | |
| Drug | benzphetamine | 1.25e-04 | 119 | 49 | 4 | CID000002341 | |
| Drug | 2,3-PDCA | 1.26e-04 | 8 | 49 | 2 | CID000127037 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 1.26e-04 | 8 | 49 | 2 | ctd:C489827 | |
| Drug | NADP(H | 1.27e-04 | 527 | 49 | 7 | CID000000930 | |
| Drug | amoxapine | 1.33e-04 | 46 | 49 | 3 | CID000002170 | |
| Drug | naphthalene | 1.42e-04 | 123 | 49 | 4 | CID000000931 | |
| Drug | Clofibric Acid | 1.47e-04 | 727 | 49 | 8 | ctd:D002995 | |
| Drug | Mirex | 1.51e-04 | 48 | 49 | 3 | ctd:D008917 | |
| Drug | heliotrine | 1.51e-04 | 48 | 49 | 3 | ctd:C010178 | |
| Drug | 3 -hydroxypregn-5-en-20-one | 1.57e-04 | 238 | 49 | 5 | CID000001027 | |
| Drug | Phosphates | 1.61e-04 | 49 | 49 | 3 | ctd:D010710 | |
| Drug | Lithocholic Acid | 1.63e-04 | 240 | 49 | 5 | ctd:D008095 | |
| Drug | C7 5 | 2.02e-04 | 10 | 49 | 2 | CID004248455 | |
| Drug | 18-HETE | 2.02e-04 | 10 | 49 | 2 | CID006442778 | |
| Drug | 9-hydroxybenzo(a)pyrene | 2.03e-04 | 53 | 49 | 3 | CID000028598 | |
| Drug | nifedipine | 2.55e-04 | 415 | 49 | 6 | CID000004485 | |
| Drug | 17-ODYA | 2.94e-04 | 60 | 49 | 3 | CID000001449 | |
| Drug | pyrrolidine-2,4-dicarboxylate | 3.09e-04 | 61 | 49 | 3 | CID000003868 | |
| Drug | BP-4,5-oxide | 3.09e-04 | 61 | 49 | 3 | CID000037786 | |
| Drug | methylglucamine | 3.24e-04 | 62 | 49 | 3 | CID000004049 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 3.45e-04 | 155 | 49 | 4 | 6817_DN | |
| Drug | azo analog I | 3.49e-04 | 13 | 49 | 2 | CID006438575 | |
| Drug | 3-hydroxyhexadecanoic acid | 3.49e-04 | 13 | 49 | 2 | CID000301590 | |
| Drug | anthglutin | 3.49e-04 | 13 | 49 | 2 | CID000125748 | |
| Drug | NO-711 | 3.90e-04 | 66 | 49 | 3 | CID000004515 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 3.98e-04 | 161 | 49 | 4 | 3556_DN | |
| Drug | bioallethrin | 4.06e-04 | 14 | 49 | 2 | ctd:C018465 | |
| Drug | 7-BFC | 4.06e-04 | 14 | 49 | 2 | CID000848780 | |
| Drug | N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine | 4.44e-04 | 69 | 49 | 3 | CID000003172 | |
| Drug | aminotriazole | 4.57e-04 | 167 | 49 | 4 | CID000001639 | |
| Drug | Ro106-9920 | 4.68e-04 | 15 | 49 | 2 | CID003906779 | |
| Drug | diamidine | 4.68e-04 | 15 | 49 | 2 | CID000008813 | |
| Drug | Betamethasone-d5 | IGF1R SLC34A1 SCN10A CYP4F2 CYP4F3 CD46 CYP4F12 CYP39A1 ITGB1 CYP4F11 | 4.82e-04 | 1340 | 49 | 10 | CID000003003 |
| Drug | 1-aminobenzotriazole | 4.83e-04 | 71 | 49 | 3 | CID000001367 | |
| Disease | low tension glaucoma (implicated_via_orthology) | 2.69e-05 | 5 | 49 | 2 | DOID:13544 (implicated_via_orthology) | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 4.04e-05 | 6 | 49 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 9.65e-05 | 9 | 49 | 2 | EFO_0800562 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.21e-04 | 10 | 49 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.21e-04 | 10 | 49 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.57e-04 | 163 | 49 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.76e-04 | 12 | 49 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | unipolar depression, mood disorder, response to antidepressant | 2.43e-04 | 14 | 49 | 2 | EFO_0003761, EFO_0004247, GO_0036276 | |
| Disease | Epilepsy, Cryptogenic | 3.48e-04 | 82 | 49 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 3.48e-04 | 82 | 49 | 3 | C0751111 | |
| Disease | Aura | 3.48e-04 | 82 | 49 | 3 | C0236018 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 4.54e-04 | 19 | 49 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 4.54e-04 | 19 | 49 | 2 | C0587248 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 4.54e-04 | 19 | 49 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 4.54e-04 | 19 | 49 | 2 | C1275081 | |
| Disease | hypertension (biomarker_via_orthology) | 5.51e-04 | 227 | 49 | 4 | DOID:10763 (biomarker_via_orthology) | |
| Disease | LEOPARD Syndrome | 6.11e-04 | 22 | 49 | 2 | C0175704 | |
| Disease | Noonan Syndrome | 7.28e-04 | 24 | 49 | 2 | C0028326 | |
| Disease | osteonecrosis | 7.91e-04 | 25 | 49 | 2 | EFO_0004259 | |
| Disease | Left ventricular mass to end-diastolic volume ratio | 7.91e-04 | 25 | 49 | 2 | EFO_0010556 | |
| Disease | Brain Diseases | 7.91e-04 | 25 | 49 | 2 | C0006111 | |
| Disease | Epilepsy | 7.98e-04 | 109 | 49 | 3 | C0014544 | |
| Disease | Encephalopathies | 9.23e-04 | 27 | 49 | 2 | C0085584 | |
| Disease | azoospermia (implicated_via_orthology) | 9.23e-04 | 27 | 49 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 9.93e-04 | 28 | 49 | 2 | DOID:7998 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.04e-03 | 702 | 49 | 6 | C0009402 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.13e-03 | 713 | 49 | 6 | EFO_0005689 | |
| Disease | creatinine measurement | 1.21e-03 | 995 | 49 | 7 | EFO_0004518 | |
| Disease | clopidogrel metabolite measurement | 1.38e-03 | 33 | 49 | 2 | EFO_0007966 | |
| Disease | peak expiratory flow | 1.39e-03 | 498 | 49 | 5 | EFO_0009718 | |
| Disease | QRS duration | 1.51e-03 | 298 | 49 | 4 | EFO_0005055 | |
| Disease | triacylglycerol 58:8 measurement | 1.55e-03 | 35 | 49 | 2 | EFO_0010442 | |
| Disease | phospholipid measurement | 1.64e-03 | 140 | 49 | 3 | EFO_0004639 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VQILIKCIVVLQGLP | 1171 | Q96N23 | |
| GPVVAGVLVAILVLA | 701 | Q9H013 | |
| IIGITVLVVAVPEGL | 411 | P23634 | |
| PIVAGVVAGIVLIGL | 731 | P05556 | |
| VPIVGIVAGLVLLVA | 306 | P01893 | |
| GVCVVSGIVLLALPI | 391 | Q8TAE7 | |
| KVAVLEILGAVCLVP | 216 | Q86T65 | |
| VVLPLARIATVVIGG | 26 | P40305 | |
| VIAIVVGVAVICVVP | 351 | P15529 | |
| FVGSLPVIVVGRLKV | 306 | Q643R3 | |
| VTVVLCVVLLAVPVG | 466 | A6NDA9 | |
| LIIALPVAVLLIVGG | 936 | P08069 | |
| VLVGITVPLVGLLVG | 386 | P09131 | |
| LIPVGLRVVAIQGVK | 106 | Q92915 | |
| TIVLPVIGAIVVGLC | 381 | Q9UQV4 | |
| EEVVVTLKVLIGAVP | 451 | A6NFX1 | |
| VPIVGIVAGLAVLAV | 306 | P01889 | |
| VIGPVLAVVFIICIV | 1286 | Q13332 | |
| PVAGLVVGILVTVLV | 146 | Q06495 | |
| VIGIIIVIIIHPGKG | 136 | P43003 | |
| GRVIPKGIVCLINII | 411 | Q9HBI6 | |
| GRVIPKGITCLIDII | 411 | Q9HCS2 | |
| LLVVVGVLSVGIVLP | 161 | Q5T3F8 | |
| IPALVILGIVVFKIR | 631 | Q9H222 | |
| GRVIPKGIICLISVF | 411 | P78329 | |
| EVVRLVKPTAIIGVA | 401 | Q16798 | |
| ATVKVVLIPVGQEIV | 131 | Q8NA54 | |
| PGVITRKVVKPVEIL | 341 | Q9NYL5 | |
| GRVIPKGIICLISVF | 411 | Q08477 | |
| VVKAVVLPGRVTAIE | 116 | Q8WYP5 | |
| QPVGLIRVHKVLVVG | 291 | Q8NFJ9 | |
| VILGIVLVVSIKPGV | 106 | P43005 | |
| VGPVLAVVFIICIVI | 1271 | P23468 | |
| IPIIKGGTVVKLIER | 596 | Q07890 | |
| VAIPVKVIAIEVNGL | 461 | Q6IEE7 | |
| PVAKLAIRVGLAVVG | 221 | Q9NX61 | |
| VVLVILLIRGVTLPG | 431 | Q9Y345 | |
| RVVIIGAGKPAAVVL | 891 | Q14697 | |
| AGIPIIKAGTVIKLI | 596 | Q07889 | |
| LLGPKVLLVVGVSVI | 376 | Q5TFQ8 | |
| LTLTRKEPVGVCGII | 556 | O75891 | |
| VGVGVPVVFIIILVL | 556 | O95436 | |
| VVVAPGADVLLKCII | 731 | Q15772 | |
| VIVGIVVGGVLVKRL | 421 | O94956 | |
| VSVIPGLKVIVGALI | 226 | Q9Y5Y9 | |
| RGGVAIKIPIVCVVL | 316 | O94759 | |
| PRKIGVCIIVLVGDV | 36 | Q9BTD3 | |
| ISVIPGLKTIVGALI | 231 | Q9UQD0 | |
| VLVVIVTFGIILPLC | 196 | Q9H2H9 |